BioNeutra Global Corporation (BGACF) Stock
BioNeutra Global Corporation, along with its associated companies, specializes in the development, manufacturing, and marketing of food ingredients. These ingredients are designed for use in nutraceuticals, functional foods, and conventional food and beverage products, with a particular emphasis on oligosaccharides.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About BioNeutra Global Corporation
BioNeutra Global Corporation, along with its associated companies, specializes in the development, manufacturing, and marketing of food ingredients. These ingredients are designed for use in nutraceuticals, functional foods, and conventional food and beverage products, with a particular emphasis on oligosaccharides. The company's primary offering is VitaFiber, an isomalto-oligosaccharide (IMO) that serves as a functional health food ingredient. This unique component delivers low-calorie, soluble prebiotic fiber, significantly supporting human digestive well-being. BioNeutra supplies a diverse clientele, encompassing both small-to-medium enterprises and various larger food manufacturers, with its market presence spanning across Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. VitaFiber is also made accessible directly to consumers via e-commerce platforms like Amazon.com and Shopify.com, in addition to other direct-to-consumer retail avenues. The corporation maintains its headquarters in Edmonton, Canada.
BioNeutra Global Corporation is headquartered in CA.
BioNeutra Global Corporation (BGACF) stock trades at $0.01 with a market capitalization of $260113. The stock is valued at a price-to-earnings (P/E) ratio of -0.16, price-to-book of -0.06, price-to-sales of 0.03. Over the past 52 weeks the stock has ranged between $0.01 and $0.01, and currently trades at its 52-week high.
On profitability, BioNeutra Global Corporation generates a return on equity (ROE) of 42.37% — well above the market average, a sign of a high-quality business, return on capital employed of -146.25%, an operating margin of -12.63%, a net profit margin of -18.52%.
Official website: www.bioneutra.ca